Physician profile
Heather Sutton
NPI 1700485794
$422.29
in general payments reported to CMS, 2019-2025
11 companies · $79.00 in 2025
The $79.00 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.73 · 2022: $29.76 · 2023: $231 · 2024: $49.66 · 2025: $79.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $97.35 | 2023 | Xarelto |
| Janssen Pharmaceuticals, INC | $89.31 | 2023 | Xarelto |
| Smith+Nephew, INC. | $85.14 | 2022-2024 | Allevyn Life L 15.4x15.4 Ctn10, Stravix, Grafix Pl |
| Vertex Pharmaceuticals Incorporated | $26.53 | 2025 | |
| Kerecis Limited | $23.58 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Reprise Biomedical, INC. | $18.06 | 2025 | Miro3d |
| Solventum Corporation | $17.64 | 2025 | Promogran Prisma, V.A.C. Veraflo, 3m Cavilon |
| Kci USA, INC. | $17.07 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.77 | 2025 | Gattex |
| Integra Lifesciences Corporation | $15.66 | 2021 | |
| Medline Industries LP | $15.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.